Jefferies Cuts Price Target on GTx, Inc. (GTXI) to $7 Following Enobosarm Trial Results

Go back to Jefferies Cuts Price Target on GTx, Inc. (GTXI) to $7 Following Enobosarm Trial Results
GTX, Inc. (NASDAQ: GTXI) Delayed: 1.20 --0 (-0%)
Previous Close $1.20    52 Week High $1.12 
Open $24.29    52 Week Low $0.32 
Day High $1.20    P/E N/A 
Day Low $1.20    EPS $-0.75 
Volume 202